Human carriers of IL-1B polymorphisms (IL-1B-511T and IL-1B-31C) show enhanced IL-1β production and increased circulating levels of the cytokine, resulting in an increased risk of cancers [17]. The gene discussed is IL1B; the disease is cancer.